Wei-Chao Chang
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 3
- Oncology top 5%
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 3
- Immunology top 5%
- Molecular Biology top 5%
- Pluripotent Stem Cells Research 3
- RNA modifications and cancer 3
-
- Ferroptosis and cancer prognosis 2
-
- Lysosomal Storage Disorders Research 2
-
- Sperm and Testicular Function 2
- Co-authors
- Mien‐Chie HungLing‐Chu ChangShuen‐Ei ChenRuey‐Hwang ChouYung‐Luen YuChung‐Hsuan ChenJennifer L. HsuDihua Yu
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei-Chao Chang
32 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 734
- Oncology 648
- Immunology 465
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 529
Countries citing papers authored by Wei-Chao Chang
This map shows the geographic impact of Wei-Chao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chao Chang more than expected).
Fields of papers citing papers by Wei-Chao Chang
This network shows the impact of papers produced by Wei-Chao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chao Chang. The network helps show where Wei-Chao Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei-Chao Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 13 | |
| 3 | 2019 | 18 | |
| 4 | 2019 | 13 | |
| 5 | Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosisbreakdown → | 2017 | 443 |
| 6 | 2017 | 33 | |
| 7 | 2016 | 203 | |
| 8 | 2015 | 52 | |
| 9 | 2014 | 26 | |
| 10 | 2013 | 15 | |
| 11 | 2013 | 293 | |
| 12 | 2012 | 40 | |
| 13 | 2011 | 144 | |
| 14 | 2011 | 76 | |
| 15 | 2010 | 53 | |
| 16 | 2008 | 18 | |
| 17 | 2008 | 41 | |
| 18 | 2006 | 16 | |
| 19 | 2002 | 0 | |
| 20 | 1996 | 18 |
About Wei-Chao Chang
Wei-Chao Chang is a scholar working on Oncology, Reproductive Medicine and Biotechnology, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), HER2/EGFR in Cancer Research (3 papers), Pluripotent Stem Cells Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), RNA modifications and cancer (3 papers), Lysosomal Storage Disorders Research (2 papers), Ferroptosis and cancer prognosis (2 papers) and Sperm and Testicular Function (2 papers). The work is most often cited by research in Cancer Research (734 citations), Oncology (648 citations) and Immunology (465 citations). Wei-Chao Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mien‐Chie Hung, Ling‐Chu Chang, Shuen‐Ei Chen, Ruey‐Hwang Chou, Yung‐Luen Yu, Chung‐Hsuan Chen, Jennifer L. Hsu, Dihua Yu, Weiya Xia and Jia Shen. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.